Sei Investments Co. Purchases 14,566 Shares of Chemed Corporation $CHE

Sei Investments Co. increased its position in Chemed Corporation (NYSE:CHE) by 32.6% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 59,243 shares of the company’s stock after buying an additional 14,566 shares during the quarter. Sei Investments Co.’s holdings in Chemed were worth $22,381,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the business. BNP Paribas Financial Markets increased its stake in shares of Chemed by 14.5% in the fourth quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock valued at $14,985,000 after buying an additional 4,430 shares during the period. Abacus FCF Advisors LLC acquired a new position in shares of Chemed in the fourth quarter worth approximately $5,935,000. TD Asset Management Inc lifted its stake in shares of Chemed by 7.5% in the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after acquiring an additional 22,715 shares during the period. Epoch Investment Partners Inc. boosted its holdings in Chemed by 4.9% in the fourth quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock valued at $137,945,000 after acquiring an additional 15,133 shares during the last quarter. Finally, C WorldWide Group Holding A S bought a new stake in Chemed in the fourth quarter valued at approximately $2,189,000. Institutional investors own 95.85% of the company’s stock.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 3.33% of the stock is owned by corporate insiders.

Chemed Trading Up 1.3%

NYSE CHE opened at $516.09 on Wednesday. The stock has a market capitalization of $6.85 billion, a P/E ratio of 28.12, a P/E/G ratio of 1.88 and a beta of 0.52. The business has a 50 day simple moving average of $461.43 and a 200 day simple moving average of $434.63. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. Chemed Corporation has a one year low of $365.20 and a one year high of $520.01.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. The firm had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company’s revenue was up 8.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Research analysts expect that Chemed Corporation will post 22.67 earnings per share for the current year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s payout ratio is presently 13.08%.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Bank of America increased their price objective on shares of Chemed from $450.00 to $510.00 and gave the stock a “neutral” rating in a research report on Thursday, July 9th. Wall Street Zen downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Finally, Royal Bank Of Canada boosted their target price on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Chemed presently has a consensus rating of “Hold” and a consensus target price of $480.25.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.